Anaptysbio (ANAB) Property, Plant & Equipment (Net) (QoQ) (2017 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Anaptysbio | 1.60 Bn | 1.31 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -6.57% |
| Dec 31, 2025 | -8.67% |
| Sep 30, 2025 | -7.86% |
| Jun 30, 2025 | -6.49% |
| Mar 31, 2025 | -5.84% |
| Dec 31, 2024 | 7.00% |
| Sep 30, 2024 | -5.73% |
| Jun 30, 2024 | -6.19% |
| Mar 31, 2024 | -6.86% |
| Dec 31, 2023 | -6.92% |
| Sep 30, 2023 | 11.42% |
| Jun 30, 2023 | 2.07% |
| Mar 31, 2023 | -5.12% |
| Dec 31, 2022 | 5.93% |
| Sep 30, 2022 | -4.23% |
| Jun 30, 2022 | -4.76% |
| Mar 31, 2022 | -5.30% |
| Dec 31, 2021 | -5.39% |
| Sep 30, 2021 | -3.01% |
| Jun 30, 2021 | 41.85% |
| Mar 31, 2021 | -1.63% |
| Dec 31, 2020 | 12.49% |
| Sep 30, 2020 | 6.02% |
| Jun 30, 2020 | -7.14% |
| Mar 31, 2020 | -0.49% |
| Dec 31, 2019 | -4.54% |
| Sep 30, 2019 | 14.45% |
| Jun 30, 2019 | -6.50% |
| Mar 31, 2019 | 9.62% |
| Dec 31, 2018 | 7.51% |
| Sep 30, 2018 | 23.76% |
| Jun 30, 2018 | 64.80% |
| Mar 31, 2018 | -0.90% |
| Dec 31, 2017 | 29.63% |
| Sep 30, 2017 | -5.52% |
| Jun 30, 2017 | -4.57% |
| Mar 31, 2017 | 20.81% |